Your session is about to expire
← Back to Search
Bemnifosbuvir for COVID-19
Study Summary
This trial will test if a drug, BEM, is safe & effective for adults who have COVID-19 & are at risk for severe disease. Participants will get BEM or a placebo & may also get standard of care for 60 days.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I haven't taken hydroxychloroquine or amiodarone in the last 3 months.You are 70 years or older, or 55 years or older with certain health conditions, or 50-54 years with specific health conditions, or 18 years or older with certain medical conditions or receiving certain treatments that weaken the immune system.I was hospitalized for COVID-19 within the last 90 days.I do not have any active infections like the flu or RSV.I am on dialysis or have severe kidney problems.I have severe or critical COVID-19.I have severe liver problems.You tested positive for COVID-19 within the last 5 days before joining the study.I am starting or planning to start remdesivir for my current COVID-19 infection.I have mild or moderate COVID-19, started showing symptoms within the last 5 days, and still have at least one symptom.
- Group 1: Bemnifosbuvir (BEM)
- Group 2: Placebo
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has Bemnifosbuvir (BEM) received clearance from the FDA?
"Bemnifosbuvir (BEM)'s safety is highly regarded with a score of 3, since it has gone through rigorous trials and been verified to have efficacy."
What is the cumulative figure of individuals involved in this exploration?
"Indeed. According to clinicaltrials.gov, this research project is actively recruiting patients, with the original post appearing on November 25th 2022 and the most recent update occurring one day later. This experiment aims to admit 1500 people at a single location."
Is there an open enrollment period for this clinical research?
"Affirmative. Clinicaltrials.gov lists this clinical trial as actively recruiting participants, with the first posting on November 25th 2022 and a recent update being made on the 26th of that same month. 1500 people must be recruited from one medical centre for completion."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger